Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?

Author： MacPhee Iain AM   Fredericks Salim   Holt David W  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.15, 2005-12, pp. : 2593-2605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation

By Szekeres Thomas   Haushofer Alexander  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 163-168

Future Medicine

Access to resources Recommend Favorite

The Pharmacogenetics of Immunosuppression for Organ Transplantation: A Route to Individualization of Drug Administration

By Fredericks S.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 5, 2003-01 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs

By Kurzawski Mateusz   Droździk Marek  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1099-1118

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphisms in Relation to Immunosuppressive Drug Pharmacokinetics in Organ Transplantation: Current Knowledge and Perspectives

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 1, 2008-03 ,pp. : 56-62

Bentham Science Publishers

Access to resources Recommend Favorite

Basic immunosuppressive drugs outside solid organ transplantation

By Braun Felix   Behrend Matthias  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 267-291

Informa Healthcare

Access to resources Recommend Favorite